Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase NA 7Phase 2 6Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 60Sarcoma 4Gynecologic 4Genitourinary 4Gastrointestinal 4Dermatologic 4Breast 4Thoracic 3Head & Neck 3Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Endocrine 1

Conditions

Neuroendocrine Tumors 18Pituitary Neoplasms 5Pheochromocytoma 3Insulinoma 3Thyroid Carcinoma, Anaplastic 2Pituitary ACTH Hypersecretion 2Paraganglioma 2Neuroblastoma 2Multiple Endocrine Neoplasia Type 1 2Meningioma 2Lung Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Carcinoid Tumor 2Breast Neoplasms 2Adrenocortical Carcinoma 2Adrenal Gland Neoplasms 2von Hippel-Lindau Disease 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Sexual Infantilism 1Serotonin Syndrome 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroma, Acoustic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Brain Neoplasms × Endocrine × Clear all
NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
CNSEndocrine

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡